Phase I dose escalation study of lestaurtinib in patients with myelofibrosisElizabeth O. Hexner, Robert S. Hoffman, Maria R. Baer et al.|Leukemia & lymphoma/Leukemia and lymphoma|2015Cited by 34
Interim Analysis of the Myeloproliferative Disorders Research Consortium (MPD-RC) 112 Global Phase III Trial of Front Line Pegylated Interferon Alpha-2a Vs. Hydroxyurea in High Risk Polycythemia Vera and Essential ThrombocythemiaJohn Mascarenhas, Robert S. Hoffman, Josef T. Prchal et al.|Blood|2016Cited by 28